AbnomX

AbnomX develops software platforms for antibody sequence and immune repertoire analysis to accelerate antibody discovery.

2017 Founded1 Person on the graph

Overview

AbnomX offers the Antibody-Extractor platform, a software with algorithms dedicated to antibody sequence and repertoire analysis that accelerates phage-display and NGS-based antibody discovery. The company also provides an API for bioinformaticians and developers, and is developing TCR-Profiler for TCR sequence analysis.

Key people

Something wrong or missing? Send an update. Fixed within 24 hours.